Gonadoblastoma-Associated Mixed Gonadal Germ Cell Tumor with Dysgerminoma and Hepatoid Yolk Sac Tumor Components in 46XY Gonadal Dysgenesis

Hughes, 2006, Consensus statement on management of intersex disorders, J Pediatr Urol, 2, 148, 10.1016/j.jpurol.2006.03.004 Hennes, 2012, Molecular genetic analysis of bilateral ovarian germ cell tumors, Klin Padiatr, 224, 359, 10.1055/s-0032-1327606 McCann-Crosby, 2014, State of the art review in gonadal dysgenesis: challenges in diagnosis and management, Int J Pediatr Endocrinol, 2014, 4, 10.1186/1687-9856-2014-4 Ebert, 2018, Normal pelvic ultrasound or MRI does not rule out neoplasm in patients with gonadal dysgenesis and Y chromosome material, J Pediatr Urol, 14, 154.e1, 10.1016/j.jpurol.2017.11.009 Cossu-Rocca, 2006, Cytokeratin and CD30 expression in dysgerminoma, Hum Pathol, 37, 1015, 10.1016/j.humpath.2006.02.018 Murugaesu, 2006, Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment, J Clin Oncol, 24, 4862, 10.1200/JCO.2006.06.2489 Prat, 1982, Hepatoid yolk sac tumor of the ovary (endodermal sinus tumor with hepatoid differentiation): a light microscopic, ultrastructural and immunohistochemical study of seven cases, Cancer, 50, 2355, 10.1002/1097-0142(19821201)50:11<2355::AID-CNCR2820501122>3.0.CO;2-7 Horie, 2000, Hepatoid variant of yolk sac tumor of the testis, Pathol Int, 50, 754, 10.1046/j.1440-1827.2000.01102.x